Another study using NLRP3−/−, ASC−/−, and caspase-1−/− mice also found that hepatic steatosis and inflammation in NASH were indeed associated with activation of the NLRP3 inflammasome (Henao-Mejia et al., 2012). This evidence concerns the gene NLRP3 and fatty liver disease.